NCT06874803 (WARMED) is a NA clinical trial of Acupuncture and Moxibustion (AM) in Parkinson's Disease (PD), sponsored by Jiani Wu.

Who is sponsoring NCT06874803?

NCT06874803 is sponsored by Jiani Wu.

What drugs are being tested in NCT06874803?

Interventions in NCT06874803: Acupuncture and Moxibustion (AM), Sham Acupuncture and Moxibustion (Sham-AM).

What condition does NCT06874803 study?

NCT06874803 studies Parkinson's Disease (PD).

Is NCT06874803 still recruiting?

NCT06874803 is currently recruiting now. Last updated 20 July 2025.

Last reviewed 2025-07-20 · How we verify

NCT06874803: WARMED

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Acupuncture and Moxibustion for Motor Symptoms in Early Parkinson's Disease

Recruiting now NA Last updated 20 July 2025

What this trial tests

NA trial testing Acupuncture and Moxibustion (AM) in Parkinson's Disease (PD) in 60 participants. Currently enrolling.

Timeline

1 August 2024

Primary endpoint
31 August 2025

31 August 2026

Quick facts

Lead sponsor	Jiani Wu
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	60
Start date	1 August 2024
Primary completion	31 August 2025
Estimated completion	31 August 2026
Sites	1 location across China

Drugs / interventions tested

Acupuncture and Moxibustion (AM)
Sham Acupuncture and Moxibustion (Sham-AM)

Conditions studied

Parkinson's Disease (PD) — all drugs for Parkinson's Disease (PD) →

Sponsor

Jiani Wu

Who can join

Adults 30 to 80, any sex, with Parkinson's Disease (PD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study evaluates the clinical effect and safety of acupuncture combined with moxibustion in improving motor symptoms of early-stage Parkinson's Disease (PD) patients, by assessing the changes in UPDRS scores. It also explores objective factors affecting the acupuncture effect and investigates the functional MRI mechanisms of acupuncture in PD treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parkinson's Disease (PD)

Currently open trials in the same condition.

NCT07322887 — A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreate · Phase 2 · recruiting
NCT07348705 — Electrophysiology-based DBS Programming for PD · NA · recruiting
NCT07316296 — Pharmacologically Modulating the Noradrenergic Arousal System to Reduce Freezing of Gait in Parkinson's Disease: a Multi · Phase 3 · recruiting
NCT07417280 — LIFUS For Neurological Disorders · NA · recruiting
NCT07310264 — Research Into the Safety of a New Agent (VT-5006) in People With and Without Parkinson's Disease · Phase 1 · recruiting

Other Jiani Wu trials

Trials by the same sponsor.

NCT06287970 — TaVNS Improves the Symptoms of Patients With Moderate to Severe CP/CPPS · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06874803 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jiani Wu
Last refreshed: 20 July 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06874803.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing